2096. Evaluation of a Midline Catheter Program and Effect on Central Line Associated Blood Stream Infections
Session: Poster Abstract Session: Healthcare Epidemiology: Device-associated HAIs
Saturday, October 6, 2018
Room: S Poster Hall
  • Midline Poster Final Draft.pdf (364.9 kB)
  • Background:

    Central line associated blood stream infections (CLABSI) result in increased patient morbidity. Guidelines recommend against peripheral venous catheters when access is required for longer than 6 days, often leading to central venous catheter (CVCs) placement.  To improve vascular access device choice and reduce the potential risk of CLABSIs, we implemented a quality improvement initiative compromised of a new vascular access algorithm with introduction of midline utilization and sought to evaluate the impact of midline use on CLABSI rates.


    A prospective quality improvement assessment from October 2017 through March 2018 analyzed the infection rates of midline catheters and CVCs.  When a consult was placed for a peripherally inserted central catheter (PICC) that the patient would be evaluated via the vascular access algorithm (Figure 1) for whether they should receive a midline catheter, a PICC or a traditional CVC.  The midline catheters, PICCs, and CVCs were monitored for duration of indwell and bloodstream infections consistent with reportable CLABSI definitions.


    In the month prior to implementation, the institutional CLABSI rate was 1.36 per 1000 CVC (including PICC) days. Since October 2017, there have been 4588 midline catheter days, with 2 midline infections, for a cumulative rate over those 6 months of 0.435 midline catheter infections per 1000 midline days.  This was compared to 26,575 CVC days, with 33 documented CLABSIs, for a rate of 1.242 per 1000 CVC days.  Since the vascular algorithm was implemented, the infection rate from the compilation of CVC and midline catheters is 1.12 per 1000 catheter days.


    The implementation of a vascular access algorithm including midlines may effectively reduce central line insertions and thereby decrease CLABSIs through appropriate utilization of a lower risk device (midline). Further research into comparing additional risks, benefits, complications and costs of midline catheters and all styles of central venous catheters is warranted.

    Richard Hankins, MD1, Mark E. Rupp, MD2, Teresa Micheels, MSN, RN, CIC3, Adrienne Sy, RN, BSN4, Angela Boesch, RN, BSN4, Kim Hayes, RN4, Luana Evans, MBA, BS4 and Kelly Cawcutt, MD4, (1)Infectious Disease, University of Nebraska Medical Center, Omaha, NE, (2)Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, (3)Infection Control and Epidemiology, Nebraska Medicine, Omaha, NE, (4)University of Nebraska Medical Center, Omaha, NE


    R. Hankins, None

    M. E. Rupp, None

    T. Micheels, None

    A. Sy, None

    A. Boesch, None

    K. Hayes, None

    L. Evans, None

    K. Cawcutt, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.